SCHEMBL9434374

SCHEMBL9434374

CCOC(=O)C1=C(C)c2c(C)c3c(cc2=N1)-c1cc(Br)ccc1N=3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 2/20 0.39
APAF1 O14727 1/20 0.39
HTT P42858 1/20 0.39
KDM1A O60341 1/20 0.37
ESR1 P03372 1/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GABRG2 P18507 3/20 0.36
GABRB3 P28472 3/20 0.36
GABRA5 P31644 3/20 0.36
GABRA1 P14867 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 1/20 0.36
GABRA6 Q16445 1/20 0.36
ALOX5 P09917 4/20 0.35
MAPT P10636 2/20 0.34
ATM Q13315 1/20 0.34
GABRB1 P18505 1/20 0.33
GABRB2 P47870 1/20 0.33
PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8909629 0.90 CA12 (0.39) HTTESR1ALDH1A1SMN1; SMN2GABRG2
SCHEMBL8911562 0.86 POLB (0.40) HTTALDH1A1GABRG2GABRB3GABRA5
SCHEMBL8912086 0.86 CYP2C9 (0.39) HTTESR1ALDH1A1MAPTNPSR1
SCHEMBL1388815 0.85 MAPT (0.44) APAF1HTTALDH1A1SMN1; SMN2GABRG2
SCHEMBL8910230 0.84 GABRA1 (0.38) ALDH1A1SMN1; SMN2GABRG2GABRB3GABRA5
SCHEMBL1388445 0.78 CA12 (0.37) APAF1HTTALDH1A1SMN1; SMN2GABRG2
SCHEMBL9434967 0.75 MAPT (0.42) APAF1HTTALDH1A1SMN1; SMN2GABRG2
SCHEMBL8156114 0.74 CHRM2 (0.38) ALDH1A1MAPTGAA
SCHEMBL8150571 0.73 HTT (0.32) APAF1HTTALDH1A1SMN1; SMN2MAPT
SCHEMBL8150139 0.72 RAB9A (0.33) HTTALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed